Loading clinical trials...
Loading clinical trials...
This study aims to assess the safety of ARGX-213 in healthy adults. Another aim is to measure the amount of ARGX-213 in the blood over time to learn how it moves through the body and acts in the body....
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
argenx
NCT05545306 · Obesity, Normal Physiology, and more
NCT06649110 · Healthy Volunteers, Pulmonary Arterial Hypertension
NCT00104325 · Healthy Volunteers
NCT07118891 · Vasomotor Symptoms Associated With Menopause, Healthy Volunteers
NCT01399385 · Healthy, Obesity, and more
Altasciences
Montreal
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions